Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Cosmetics Office Aims To Achieve Three “A” List Priorities In 2002
Feb 04 2002
•
By
The Rose Sheet
More from Archive
More from HBW Insight